Recurrent Peritoneal Cancer
1 clinical trials · Condition
◉ Watch Recurrent Peritoneal Cancer
| Record | Firm | Date |
|---|---|---|
| Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer (NCT02785250) | ImmunoVaccine Technologies, Inc. (IMV Inc.) | 2016-04-01 |
Track Recurrent Peritoneal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.